Measurement Invariance of the Manchester Orofacial Pain Disability Scale (MOPDS) for Biopsychosocial Factor Among Orofacial Patients and Nonclinical Populations: An Evidence for Clinical Investigations.
Orofacial pain (OFP) harms mental health and functionality. The Manchester Orofacial Pain Disability Scale (MOPDS) is a questionnaire for assessing OFP.
The purpose of this study was to examine the validity of the Chinese version of MOPDS in clinical populations, measurement invariance across different clinical statuses and sex cohorts.
This study recruited 387 OFP clinical patients. Confirmatory factor analysis (CFA) assessed the internal consistency and factor structure of the MOPDS. Pearson's correlation coefficient assessed external convergent validity. Composite reliability (CR), the average variance extracted (AVE) and the heterotrait-monotrait ratio (HTMT) were used to assess internal convergent and discriminate validity. Multigroup CFA explored the measurement invariance. T-test compared scores between sex groups across various clinical statuses.
MOPDS in the clinical sample (Cronbach's α = 0.975, McDonald's omega = 0.975) had an acceptable internal consistency. CFA supported the two-factor structure in clinical settings with physical and psychosocial dimensions, which was applicable among different sexes and clinical groups. CR, AVE, HTMT, and correlation coefficient results with other scales proved the convergent and discriminant validity of MOPDS. Multigroup CFA supported scalar measurement invariance across different clinical statuses and sex groups. The females did not have significantly higher average scores (p > 0.05), and clinical samples had significantly higher average scores (p < 0.01).
The Chinese version of MOPDS is a reliable and effective instrument in clinical settings for assessing the physical and psychosocial disabilities caused by OFP by helping to develop personalised treatment plans.
The purpose of this study was to examine the validity of the Chinese version of MOPDS in clinical populations, measurement invariance across different clinical statuses and sex cohorts.
This study recruited 387 OFP clinical patients. Confirmatory factor analysis (CFA) assessed the internal consistency and factor structure of the MOPDS. Pearson's correlation coefficient assessed external convergent validity. Composite reliability (CR), the average variance extracted (AVE) and the heterotrait-monotrait ratio (HTMT) were used to assess internal convergent and discriminate validity. Multigroup CFA explored the measurement invariance. T-test compared scores between sex groups across various clinical statuses.
MOPDS in the clinical sample (Cronbach's α = 0.975, McDonald's omega = 0.975) had an acceptable internal consistency. CFA supported the two-factor structure in clinical settings with physical and psychosocial dimensions, which was applicable among different sexes and clinical groups. CR, AVE, HTMT, and correlation coefficient results with other scales proved the convergent and discriminant validity of MOPDS. Multigroup CFA supported scalar measurement invariance across different clinical statuses and sex groups. The females did not have significantly higher average scores (p > 0.05), and clinical samples had significantly higher average scores (p < 0.01).
The Chinese version of MOPDS is a reliable and effective instrument in clinical settings for assessing the physical and psychosocial disabilities caused by OFP by helping to develop personalised treatment plans.